By Business/Source
Currency:USD
2026/Q1
Stock NameRevenueRatio
Affordable Medicines423.24M58.58%
AvKARE166.02M22.98%
Specialty133.27M18.44%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States3.02B100.00%